Indian Cervical Cancers: Understanding of Epidemiological Profile through the National Cancer Registry Programs Findings

Abstract

Abstract: According to a recent analysis from the Lancet research, India has the highest rate of cervical cancer malignancies in all of Asia. The study claims that India alone is responsible for 23% of cervical cancer-related deaths in Asia. According to the GLOBOCAN report 2020, India has a high mortality rate of 62.42%, which is higher than that of both Asia and the rest of the globe. Due to the severe lack of resources, cervical cancer is a big issue in India. Based on an analysis of data from a significant cancer registry network, this study investigates the epidemiological characteristics of cervical cancer in India in great detail. In accordance with the PBCR 2020 (ICMR-NCDIR; 2020), the truncated rate (TR) in the districts of Aizawl, Dibrugarh, and Kollam was six times, five times, and four times larger, respectively, than the TR rate in the districts of Papumpare, Mizoram, and Pasighat. In the entire country, we discovered considerable regional and socioeconomic variations in the incidence of cervical cancer, with a clear gradient of increased incidence in areas with lower levels of human development. Combining HIV testing and cervical cancer screening during a single appointment with a primary care provider would be a cost-effective option.